Matthew Sykes
Stock Analyst at Goldman Sachs
(0.97)
# 2169
Out of 5,370 analysts
243
Total ratings
51.92%
Success rate
-5.91%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
FTRE Fortrea Holdings | Maintains: Neutral | 7 5 | 5.82 | -14.09% | 4 | May 14, 2025 | |
CTKB Cytek Biosciences | Maintains: Sell | 4 3 | 3.31 | -9.37% | 9 | May 12, 2025 | |
TXG 10x Genomics | Maintains: Sell | 8 7 | 11.03 | -41.07% | 7 | May 12, 2025 | |
BRKR Bruker | Maintains: Neutral | 50 45 | 39.02 | 15.33% | 5 | May 8, 2025 | |
MYGN Myriad Genetics | Maintains: Buy | 14 8 | 4.92 | 62.6% | 12 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 48 | 35.01 | 37.1% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 17 | 11.3 | 50.44% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 180 160 | 146.97 | 8.87% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 10 | 7.4 | 35.14% | 8 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 140 125 | 96.31 | 29.79% | 2 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 14 | 13.43 | 4.24% | 6 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 240 | 200.98 | 19.41% | 5 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 26 | 19.05 | 36.48% | 10 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 190 170 | 151.28 | 12.37% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 49 56 | 49.13 | 13.98% | 13 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 70 80 | 66.78 | 19.8% | 11 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 1.38 | 8.7% | 5 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 160 190 | 168.2 | 12.96% | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 3 2 | 0.72 | 143.06% | 5 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 7 5 | 2.15 | 97.67% | 10 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 38 37 | 26.66 | 38.78% | 5 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 75 65 | 53.29 | 21.97% | 12 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 280 250 | 159.4 | 56.84% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 7 | n/a | n/a | 11 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 24 | 6.12 | 292.16% | 13 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1150 1300 | 1182.83 | 9.91% | 5 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 12 | 9.14 | 31.29% | 6 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 550 640 | 404.82 | 58.09% | 4 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 128 145 | 119.07 | 21.78% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 3 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 6 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 1 1 | n/a | n/a | 8 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 2 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 16 18 | n/a | n/a | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 1 | n/a | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 175 | n/a | n/a | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 120 60 | n/a | n/a | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | n/a | n/a | 4 | Apr 13, 2022 |